We analyzed all the experimentally resolved PIK3CA structure complexed with inhibitor before constructing the multiple receptor-ligand based pharmacophore model of PIK3CA inhibitors and further employed the receptor ligand interaction-based pharmacophore technique to reconnoitre the structure activity relationship of proposed cancer drug target PIK3CA and streptenolderivatives. Here, PIK3CA is linked to cancer.